Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37 member A6 pseudogene (LRRC37A6P) is a human pseudogene from the leucine-rich repeat-containing family, annotated as a noncoding genomic locus without any protein-coding transcripts[1][2][4][5]. It is not known to encode a functional protein and does not have a validated biological role, therapeutic target status, drug interactions, or disease associations. This gene is cataloged as a pseudogene, meaning it resembles functional genes but has lost its protein-coding potential due to evolutionary changes[1][2][4][5]. Key notes: - It is not considered a therapeutic target, receptor, enzyme, or functional protein-coding gene[2][5]. - There are no transcripts or protein products associated with LRRC37A6P[5]. - Common aliases include LRRC37E and variations of its formal name[2][4]. - No information supports involvement in signaling, disease, or druggable mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 37 member A6 pseudogene (LRRC37A6P).